S
4.89
-0.96 (-16.41%)
| Previous Close | 5.85 |
| Open | 5.64 |
| Volume | 608,808 |
| Avg. Volume (3M) | 904,774 |
| Market Cap | 33,385,750 |
| Price / Sales | 3.41 |
| Price / Book | 2.07 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
| Operating Margin (TTM) | -1,378.09% |
| Diluted EPS (TTM) | -12.07 |
| Quarterly Revenue Growth (YOY) | 5,268.80% |
| Total Debt/Equity (MRQ) | 13.66% |
| Current Ratio (MRQ) | 1.03 |
| Operating Cash Flow (TTM) | -11.62 M |
| Levered Free Cash Flow (TTM) | -7.73 M |
| Return on Assets (TTM) | -176.75% |
| Return on Equity (TTM) | -714.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Sonnet BioTherapeutics Holdings | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | -2.1 |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -1.61 |
Select this tab to load the latest available analysis.
|
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 1.53% |
| % Held by Institutions | 5.24% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |